BioNexus Gene Lab (BGLC) Competitors $2.85 -0.09 (-3.06%) Closing price 04/30/2025 04:00 PM EasternExtended Trading$2.80 -0.06 (-1.93%) As of 09:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. CCM, ENZ, MRAI, MGRX, BRTX, KDLY, SSY, OTRK, ACON, and ATIPShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Concord Medical Services (CCM), Enzo Biochem (ENZ), Marpai (MRAI), Mangoceuticals (MGRX), BioRestorative Therapies (BRTX), Kindly MD (KDLY), SunLink Health Systems (SSY), Ontrak (OTRK), Aclarion (ACON), and ATI Physical Therapy (ATIP). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Concord Medical Services Enzo Biochem Marpai Mangoceuticals BioRestorative Therapies Kindly MD SunLink Health Systems Ontrak Aclarion ATI Physical Therapy Concord Medical Services (NYSE:CCM) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Which has preferable earnings & valuation, CCM or BGLC? BioNexus Gene Lab has lower revenue, but higher earnings than Concord Medical Services. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioConcord Medical Services$471.70M0.08-$41.93MN/AN/ABioNexus Gene Lab$9.51M0.54-$2.63MN/AN/A Is CCM or BGLC more profitable? Concord Medical Services has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -10.17%. Concord Medical Services' return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets Concord Medical ServicesN/A N/A N/A BioNexus Gene Lab -10.17%-9.93%-8.43% Do insiders & institutionals hold more shares of CCM or BGLC? 18.9% of BioNexus Gene Lab shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by insiders. Comparatively, 0.7% of BioNexus Gene Lab shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community believe in CCM or BGLC? Concord Medical Services received 197 more outperform votes than BioNexus Gene Lab when rated by MarketBeat users. CompanyUnderperformOutperformConcord Medical ServicesOutperform Votes19758.81% Underperform Votes13841.19% BioNexus Gene LabN/AN/A Which has more volatility and risk, CCM or BGLC? Concord Medical Services has a beta of -0.64, suggesting that its share price is 164% less volatile than the S&P 500. Comparatively, BioNexus Gene Lab has a beta of 5.41, suggesting that its share price is 441% more volatile than the S&P 500. Does the media refer more to CCM or BGLC? In the previous week, Concord Medical Services had 1 more articles in the media than BioNexus Gene Lab. MarketBeat recorded 5 mentions for Concord Medical Services and 4 mentions for BioNexus Gene Lab. BioNexus Gene Lab's average media sentiment score of 0.59 beat Concord Medical Services' score of -0.20 indicating that BioNexus Gene Lab is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Concord Medical Services 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioNexus Gene Lab 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryConcord Medical Services beats BioNexus Gene Lab on 7 of the 12 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.12M$2.88B$5.56B$7.82BDividend YieldN/A31.29%5.11%4.22%P/E RatioN/A13.2822.5718.48Price / Sales0.54188.21395.64103.60Price / CashN/A57.5638.1834.62Price / Book5.184.676.774.25Net Income-$2.63M-$22.21M$3.22B$248.23M7 Day Performance-0.70%-1.91%1.46%0.89%1 Month Performance9.62%3.24%3.98%3.53%1 Year Performance-53.61%11.50%16.14%5.09% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.2733 of 5 stars$2.85-3.1%N/A-54.0%$5.12M$9.51M0.0030Short Interest ↑News CoverageGap DownCCMConcord Medical Services0.5906 of 5 stars$4.26+3.1%N/A-4.0%$18.50M$471.70M0.00970Short Interest ↑ENZEnzo Biochem0.5486 of 5 stars$0.33-14.8%N/A-69.0%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeMRAIMarpaiN/A$1.01-3.8%N/A-50.7%$15.05M$34.87M-0.38150Upcoming EarningsGap DownMGRXMangoceuticals0.9081 of 5 stars$2.49-3.1%N/A-97.0%$12.87M$615,873.00-0.433Short Interest ↓BRTXBioRestorative Therapies3.9703 of 5 stars$1.71-2.3%$18.00+952.6%+23.9%$12.83M$401,000.00-1.127Short Interest ↓Positive NewsKDLYKindly MD1.2822 of 5 stars$1.47-16.0%N/AN/A$8.86M$2.72M-2.23N/AShort Interest ↓Positive NewsSSYSunLink Health SystemsN/A$0.94+3.5%N/A+64.6%$6.60M$31.23M6.701,376Gap UpOTRKOntrak3.2545 of 5 stars$1.44+2.1%$45.00+3,025.0%-64.7%$6.07M$10.85M-0.14250Short Interest ↓Positive NewsACONAclarion1.5166 of 5 stars$7.93-11.7%$11,758.50+148,178.7%-99.8%$4.62M$45,724.000.007ATIPATI Physical TherapyN/A$1.00+17.6%N/A-80.9%$4.41M$741.86M-0.055,600Upcoming EarningsGap Up Related Companies and Tools Related Companies CCM Alternatives ENZ Alternatives MRAI Alternatives MGRX Alternatives BRTX Alternatives KDLY Alternatives SSY Alternatives OTRK Alternatives ACON Alternatives ATIP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BGLC Stock Free BGLC Stock Alerts